View in EDS

Recommendations for standardized pathological characterization of residual disease for neoadjuvant clinical trials of breast cancer by the BIG-NABCG collaboration.

Saved in:
Bibliographic Details
Title: Recommendations for standardized pathological characterization of residual disease for neoadjuvant clinical trials of breast cancer by the BIG-NABCG collaboration.
Authors: Bossuyt, V.1 veerle.bossuyt@yale.edu, Provenzano, E.2, Symmans, W. F.3, Boughey, J. C.4, Coles, C.5, Curigliano, G.6, Dixon, J. M.7, Esserman, L. J.8, Fastner, G.9, Kuehn, T.10, Peintinger, F.11,12, von Minckwitz, G.13, White, J.14, Yang, W.15, Badve, S.16, Denkert, C.17, MacGrogan, G.18, Penault-Llorca, F.19, Viale, G.20, Cameron, D.21
Source: Annals of Oncology. Jul2015, Vol. 26 Issue 7, p1280-1291. 12p. 2 Diagrams, 3 Charts.
Database: Academic Search Ultimate
Description
ISSN:09237534
DOI:10.1093/annonc/mdv161